Michael Morris, MD
@mjmorrismd.bsky.social
📤 674
📥 534
📝 20
Medical Oncologist and Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.
reposted by
Michael Morris, MD
The Advanced Prostate Cancer Consensus Conference
5 months ago
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive
#ProstateCancer
: the randomized, double-blind, phase III KEYNOTE-991 study
annalsofoncology.org/article/S092...
loading . . .
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study
Despite treatment advances, most patients with metastatic hormone-sensitive prostate cancer (mHSPC) experience disease progression to castration-resistant disease within 5 years. The placebo-controlled, double-blind, phase III KEYNOTE-991 study evaluated the efficacy and safety of adding pembrolizumab to enzalutamide and androgen deprivation therapy (ADT) in participants with mHSPC.
https://annalsofoncology.org/article/S0923-7534(25)00200-5/abstract
0
3
4
reposted by
Michael Morris, MD
Memorial Sloan Kettering Cancer Center
7 months ago
Congratulations to MSK's Dr. Justin Jee and Dr. Nikolaus Schultz for being accepted into Round 2 of
@statnews.com
#STATMadness
. Vote for the team “Cancer Big Data” now:
www.statnews.com/feature/stat...
0
5
4
reposted by
Michael Morris, MD
Memorial Sloan Kettering Cancer Center
7 months ago
Congratulations to MSK's Dr. Natasha Rekhtman and Dr. Charles Rudin for being accepted into Round 1 of
@statnews.com
#STATMadness
. Vote for the team “New Lung Cancer Subtype” now:
www.statnews.com/feature/stat...
0
7
3
reposted by
Michael Morris, MD
Cancer Survivors Club 📙
6 months ago
Big news in prostate cancer treatment! The
#FDA
has expanded the label for Novartis
#Pluvicto
, now approved before chemotherapy for PSMA-positive metastatic castration-resistant prostate cancer.
#TCSC
#cancerresearch
#prostatecancer
#psmafore
www.appliedclinicaltrialsonline.com/view/fda-app...
loading . . .
FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto
Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.
https://www.appliedclinicaltrialsonline.com/view/fda-approves-expanded-label-novartis-prostate-cancer-treatment-pluvicto
0
3
2
reposted by
Michael Morris, MD
Nima Sharifi MD
8 months ago
Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP).
#GU25
@charlesryanmd.bsky.social
@mjmorrismd.bsky.social
@ascopost.bsky.social
meetings.asco.org/abstracts-pr...
loading . . .
Program Guide – ASCO Meeting Program Guide
https://meetings.asco.org/abstracts-presentations/242426
0
6
2
So privileged to be among friends and colleagues for the second Feng symposium. Felix was friend and exemplar to us all.
8 months ago
2
13
2
reposted by
Michael Morris, MD
Yan Leyfman, MD
9 months ago
American Society of Clinical Oncology (ASCO) provides advisory support for the association between alcohol & cancer.
@ascocancer.bsky.social
@ascopost.bsky.social
society.asco.org/news-initiat...
loading . . .
Oncology Society Urges Americans to Heed Surgeon General Advisory on Alcohol and Cancer
The U.S. Surgeon General’s office released a new advisory on the link between alcohol consumption and increased risk for cancer. The advisory reports alcohol use as the third leading preventable cause...
https://society.asco.org/news-initiatives/policy-news-analysis/oncology-society-urges-americans-heed-surgeon-general-advisory
1
5
2
reposted by
Michael Morris, MD
Yüksel Ürün
9 months ago
AMBASSADOR Trial: Adjuvant pembrolizumab improved disease-free survival in high-risk muscle-invasive urothelial carcinoma post-surgery (29.6 vs 14.2 months; HR 0.73). Grade ≥3 AEs: 50.6%.
@nejm.org
@oncoalert.bsky.social
@erplimackmd.bsky.social
@drchoueiri.bsky.social
@oncbrothers.bsky.social
0
5
1
reposted by
Michael Morris, MD
The PCCTC
10 months ago
@thepcctc.bsky.social
is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data Science, and Clinical Operations. For more info please visit
www.linkedin.com/posts/prosta...
loading . . .
The Prostate Cancer Clinical Trials Consortium (PCCTC) on LinkedIn: PCCTC Data Management Internship, Remote in | Careers at Remote
The Prostate Cancer Clinical Trials Consortium (PCCTC) is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data…
https://www.linkedin.com/posts/prostate-cancer-clinical-trials-consortium_pcctc-data-management-internship-remote-activity-7277393100698730496-Rm9D?utm_source=share&utm_medium=member_desktop
0
2
1
Nobody capture the holiday spirit more than
@mskcancercenter.bsky.social
facilities and engineering staff. Thanks for lifting our spirits with your decorations!
10 months ago
0
15
2
reposted by
Michael Morris, MD
Toni Choueiri, MD
10 months ago
Heartbroken💔we lost Dr. Felix Feng— close friend, selfless collaborator, brilliant scientist. We miss you--too early my friend. To all: please consider supporting this ACS/ASTRO award in Felix name:
donate.cancer.org/g/tjjfqwdnrxrl…
?
loading . . .
I just helped save a life
You can save one, too. Donate now.
https://donate.cancer.org/g/tjjfqwdnrxrl…
1
16
5
reposted by
Michael Morris, MD
Miguel Perales MD
10 months ago
Telehealth Will Die In 3 Weeks Without Congressional Action
www.forbes.com/sites/judyst...
loading . . .
Telehealth Will Die In 3 Weeks Without Congressional Action
Urgent action is needed to pass the Telehealth Modernization Act before it expires, ending telemedicine on Dec. 31. This would be devastating for disabled and rural patients.
https://www.forbes.com/sites/judystone/2024/12/06/telehealth-will-die-in-3-weeks-without-congressional-action/
1
9
7
A big thank you to the GU Oncologists and Nuc Meds of CTIC in Bogota, Colombia for their hospitality and scientific discussions. Great cancer center and
#ProstateCancer
care to be sure. Hope to work together in the future! Thanks to PCF for funding this scientific exchange.
10 months ago
2
10
0
Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine
#ProstateCancer
, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and
@mishabeltran.bsky.social
aacrjournals.org/clincancerre...
loading . . .
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Abstract. Lineage plasticity and histologic transformation from prostate adenocarcinoma to neuroendocrine prostate cancer (NEPC) occurs in up to 15-20% of patients with castration-resistant prostate c...
https://aacrjournals.org/clincancerres/article-abstract/doi/10.1158/1078-0432.CCR-24-2061/750349/Framework-for-the-Pathology-Workup-of-Metastatic?redirectedFrom=fulltext
10 months ago
0
16
5
reposted by
Michael Morris, MD
Science News
11 months ago
Life could be a little bit hard for a junior scientist.
loading . . .
0
30
9
reposted by
Michael Morris, MD
Sean McBride
11 months ago
Proud of my sister. Calm, deliberative, and forward focused.
@blandro.bsky.social
youtube.com/watch?v=w2ft...
loading . . .
https://youtube.com/watch?v=w2ftQVj8KgQ
1
9
2
I remember my first-gen 128k Mac very fondly! Very musical drive noises...
add a skeleton here at some point
11 months ago
0
4
0
Thanks for the reminder! Really looking forward to the meeting this year.
add a skeleton here at some point
11 months ago
0
2
0
reposted by
Michael Morris, MD
Swapnil Hiremath 🍁🇨🇦
11 months ago
Good write up of BlueSky
#MedSky
by
@kristinafiore.bsky.social
feat. BlueSky elders:
@mdaware.org
@gavinyamey.bsky.social
@nickmark.bsky.social
@kiswanson.bsky.social
and
@kidneyboy.bsky.social
of course
www.medpagetoday.com/special-repo...
loading . . .
Physicians Flock to Bluesky, Hoping to Leave X Behind
Many compare it to the early days of Twitter
https://www.medpagetoday.com/special-reports/exclusives/113007
2
81
28
you reached the end!!
feeds!
log in
